Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation

Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in patients with atrial fibrillation (AF), and T2D patients with AF-associated stroke seem to have worse clinical outcome and higher risk of unfavorable clinical course compared to individuals without this metabolic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dana Prídavková, Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jana Žolková, Peter Kubisz, Ján Staško, Marián Mokáň
Format:	Article
Language:	English
Published:	Wiley 2019-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2019/5158308
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2 Infection-Associated Aortic Thrombosis Treated with Oral Factor Xa Inhibition
by: Alena Strýčková, et al.
Published: (2022-01-01)

The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
by: Matej Samoš, et al.
Published: (2016-01-01)

Type 2 Diabetes and ADP Receptor Blocker Therapy
by: Matej Samoš, et al.
Published: (2016-01-01)

Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review
by: Tatyana S. Degtyareva, et al.
Published: (2024-12-01)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
by: Xue Zhou, et al.
Published: (2020-01-01)

Direct Oral Anticoagulants Versus Vitamin K Antagonists After Mitral Valve Transcatheter Edge‐to‐Edge Repair in Patients With Atrial Fibrillation: A Single‐Center Observational Study
by: Jan‐Hendrik Schipper, et al.
Published: (2025-02-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia
by: Mohammed H. Alanazy, et al.
Published: (2019-01-01)

The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health‐Related Quality of Life 12 Months After Ischemic Stroke or TIA
by: Manuel C. Olma, et al.
Published: (2025-01-01)

Management Strategies in Cardiac Surgery for Postoperative Atrial Fibrillation: Contemporary Prophylaxis and Futuristic Anticoagulant Possibilities
by: George Tokmaji, et al.
Published: (2013-01-01)

Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01)

Predictors of direct oral anticoagulant concentrations in the trauma population
by: Laura Adams, et al.
Published: (2024-05-01)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
by: Raffaele De Caterina, et al.
Published: (2019-03-01)

Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment
by: Ken Okumura, et al.
Published: (2015-06-01)

Effects of Oral Inflammatory Diseases and Oral Hygiene on Atrial Fibrillation: A Systematic Review
by: Zhanxin Zhang, et al.
Published: (2023-01-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

Change in Atrial Fibrillation Burden over Time in Patients with Nonpermanent Atrial Fibrillation
by: Philipp Krisai, et al.
Published: (2020-01-01)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
by: Kimberley Doucette, et al.
Published: (2020-01-01)

Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
by: Sherif Elhosseiny, et al.
Published: (2019-01-01)

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation
by: Roberto Carnevale, et al.
Published: (2014-01-01)

Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01)

What Governs Immediate or Delayed Cardioversion of Atrial Fibrillation by Direct Current Shock?
by: Amar T. AL-Hamdi, et al.
Published: (2024-12-01)

Atrial Fibrillation: Mechanisms and Management
by: Tong Liu, et al.
Published: (2019-01-01)

Organized Atrial Tachycardias after Atrial Fibrillation Ablation
by: Sergio Castrej&#243;n-Castrej&#243;n, et al.
Published: (2011-01-01)

Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis
by: Hao Jin, et al.
Published: (2020-01-01)

To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice
by: Tania Ahuja, et al.
Published: (2023-01-01)

Carboxypeptidase B1 in dialyzed chronic kidney disease patients
by: Matej Stančík, et al.
Published: (2025-02-01)

Detecting Atrial Fibrillation Using Smartwatches
by: Agnieszka Kulczycka-Rowicka, et al.
Published: (2025-02-01)

Strategies in the Surgical Management of Atrial Fibrillation
by: Leanne Harling, et al.
Published: (2011-01-01)

Advances in Imaging for Atrial Fibrillation Ablation
by: Andrew D'Silva, et al.
Published: (2011-01-01)

Triggers for Atrial Fibrillation: The Role of Anxiety
by: Paolo Severino, et al.
Published: (2019-01-01)

Cryoballoon Catheter Ablation in Atrial Fibrillation
by: Cevher Ozcan, et al.
Published: (2011-01-01)

Real-practice thromboprophylaxis in atrial fibrillation
by: Deambrosis Paola, et al.
Published: (2017-06-01)

Integrated Management of Persistent Atrial Fibrillation
by: Xindi Yue, et al.
Published: (2025-01-01)

Recurrence of atrial fibrillation and late cardiovascular events in patients with persistent atrial fibrillation after restoration of sinus rhythm
by: U.P. Chernyaha-Royko, et al.
Published: (2020-06-01)

Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS).
by: Gregory Y H Lip, et al.
Published: (2025-01-01)

Using a Clinical Decision Support System to Improve Anticoagulation in Patients with Nonvalve Atrial Fibrillation in China’s Primary Care Settings: A Feasibility Study
by: Xueying Ru, et al.
Published: (2023-01-01)

Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation
by: Kabita Pradhan, et al.
Published: (2025-02-01)

Non-Pharmacological Therapy for Atrial Fibrillation: Managing the Left Atrial Appendage
by: Sushil Allen Luis, et al.
Published: (2012-01-01)

One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
by: Ayman Hammoudeh, et al.
Published: (2022-01-01)